Search Results - "Barnaby, R J"

Refine Results
  1. 1

    Outcrop analog for mixed siliciclastic-carbonate ramp reservoirs; stratigraphic hierarchy, facies architecture, and geologic heterogeneity; Grayburg Formation, Permian Basin, U.S.A by Barnaby, R. J, Ward, W. B

    Published in Journal of sedimentary research (01-01-2007)
    “…The Grayburg Formation (Late Permian, Guadalupian) is a shallow-marine succession flanking the Delaware and Midland basins of Texas and New Mexico, U.S.A. The…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog by Kajbaf, M., Barnaby, R. J, Bottacini, M., Bertolotti, L., Ismail, I. M, Cholerton, T. J., Pellegatti, M.

    Published in Xenobiotica (01-04-2003)
    “…1. The pharmacokinetics, metabolic fate and excretion of 3-[-2(phenylcarbamoyl) ethenyl-4,6-dichloroindole-2-carboxylic acid (GV150526), a novel glycine…”
    Get full text
    Journal Article
  5. 5

    Substituted Analogues of GV150526 as Potent Glycine Binding Site Antagonists in Animal Models of Cerebral Ischemia by Di Fabio, Romano, Conti, Nadia, De Magistris, Elisabetta, Feriani, Aldo, Provera, Stefano, Sabbatini, Fabio Maria, Reggiani, Angelo, Rovatti, Luca, Barnaby, Robert J

    Published in Journal of medicinal chemistry (09-09-1999)
    “…A series of analogues of the indole-2-carboxylate GV150526, currently in clinical trials as a potential neuroprotective agent for the control of the cerebral…”
    Get full text
    Journal Article
  6. 6

    Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in vitro-in vivo correlations by Gilissen, R. A. H. J., Ferrari, L., Barnaby, R. J., Kajbaf, M.

    Published in Xenobiotica (01-09-2000)
    “…1. The hepatic metabolism of 3-[-2(phenylcarbamoyl) ethenyl]-4,6-dichloroindole-2-carboxylic acid (GV150526), a novel glycine antagonist for stroke, was…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke by HOKE, J. F, DYKER, A. G, BARNABY, R. J, LEES, K. R

    Published in European journal of clinical pharmacology (01-02-2000)
    “…The objective of this study was to characterize the pharmacokinetics of gavestinel in patients with acute stroke. Gavestinel was administered as an 800-mg…”
    Get full text
    Journal Article
  8. 8

    Metabolism of a novel CCK-B antagonist in rat, dog and human liver microsomes by KAJBAF, M., ROSSATO, P., BARNABY, J. R., PELLEGATTI, M.

    Published in Xenobiotica (01-02-1998)
    “…1. The in vitro metabolism of a novel CCK-B antagonist ((+)-N-[1-adamantane-1-…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Automated assay for GV104326, a novel tribactam antibiotic, in human plasma by high-performance liquid chromatography and solid-phase extraction by Barnaby, R J, Iavarone, L

    Published in Journal of chromatography. A (04-02-1994)
    “…A highly automated, rapid, robust and specific plasma assay for GV104326, a novel tribactam antibiotic, has been developed to monitor human volunteer trials…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Mass assay for inositol 1-phosphate in rat brain by high-performance liquid chromatography and pulsed amperometric detection by Barnaby, R J

    Published in Analytical biochemistry (15-11-1991)
    “…A high-performance liquid chromatographic method for direct mass measurement of inositol 1-phosphate (I(1)P) in rat brain is described. Separation of I(1)P…”
    Get more information
    Journal Article
  13. 13

    Purification and properties of inositol-1,4-bisphosphatase from bovine brain by Gee, N S, Reid, G G, Jackson, R G, Barnaby, R J, Ragan, C I

    Published in Biochemical journal (01-08-1988)
    “…Inositol-1,4-bisphosphatase has been purified 13,000-fold from bovine brain supernatant. The enzyme is monomeric, with an apparent subunit Mr of 40,000…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Identification of UDP-glucuronosyltransferases involved in the human hepatic metabolism of GV150526, a novel glycine antagonist by Gilissen, R A, Barnaby, R J, Kajbaf, M

    “…The major metabolic pathway for elimination of GV150526 is by glucuronidation exerted by glucuronosyl transferases (UGTs). Potential exists for the…”
    Get more information
    Journal Article
  16. 16

    The dephosphorylation of inositol 1,4-bisphosphate to inositol in liver and brain involves two distinct Li+-sensitive enzymes and proceeds via inositol 4-phosphate by Ragan, C I, Watling, K J, Gee, N S, Aspley, S, Jackson, R G, Reid, G G, Baker, R, Billington, D C, Barnaby, R J, Leeson, P D

    Published in Biochemical journal (01-01-1988)
    “…1. Hydrolysis of both enantiomers of inositol 1-phosphate and both enantiomers of inositol 4-phosphate to inositol is inhibited by LiCl in liver and brain. 2…”
    Get full text
    Journal Article
  17. 17

    Incorporation of N-fluoroacetyl-D-glucosamine into hyaluronate by rabbit tracheal explants in organ culture by Winterbourne, D J, Barnaby, R J, Kent, P W, Mian, N

    Published in Biochemical journal (15-09-1979)
    “…1. Incubation of rabbit tracheal explants with N-[(3)H]acetyl-d-glucosamine and N-acetyl-d-[1-(14)C]glucosamine led to labelling of a number of soluble…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The new standard of care in urology outpatients? A one-stop clinic improves efficiency and quality by Barrass, Barnaby Jr, Wood, Sarah J

    Published in Journal of clinical urology (01-11-2013)
    “…Objective The objective of this article is to determine retrospectively if a one-stop clinic for all new urology referrals improved the efficiency and quality…”
    Get full text
    Journal Article
  20. 20

    Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog by Kajbaf, M, Barnaby, R J, Bottacini, M, Bertolotti, L, Ismail, I M, Cholerton, J, Pellegatti, M

    Published in Xenobiotica (01-03-2003)
    “…1. The pharmacokinetics, metabolic fate and excretion of 3-[-2(phenylcarbamoyl) ethenyl-4,6-dichloroindole-2-carboxylic acid (GV150526), a novel glycine…”
    Get full text
    Journal Article